Document is current
Any future updates will be listed below
-
Authors
Meng, Baosheng
Ma, Yuanyuan
Wang, Yuetao
Zhou, Mingge
He, Chen
-
Funding
Funding for this research was provided by:
Changzhou Clinical Medical Center (Nuclear Medicine, CZZX202204)
Changzhou Sci & Tech Program (CJ20235086)
Changzhou Talent Program (CQ20230115)
National Natural Science Foundation of China (82001858)
“333 Project” of Jiangsu Province
- License Information
-
More Information
Article History
Received: 5 August 2024
Accepted: 9 April 2025
First Online: 22 April 2025
Declarations
:
: This study was conducted in accordance with the ethical principles of the Declaration of Helsinki () and was approved by the Institutional Review Board of the Third Affiliated Hospital of Soochow University approved the study. The requirement to obtain informed consent was waived due to the retrospective nature of the study.
: Not applicable.
: The authors declare no competing interests.
: According to the thresholds of SUVmax2 and RI, patients were divided into three groups: a low-risk group (SUVmax2 ≤ 21.1 and RI ≤ 5.9%), a moderate-risk group (SUVmax2 ≤ 21.1 and RI>5.9%, or SUVmax2>21.1 and RI ≤ 5.9%), and a high-risk group (SUVmax2>21.1 and RI>5.9%).
